Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 3 21Phase 1/2 9Phase 2/3 7Phase 1 4Phase 4 2Phase NA 1

Status

Completed 17Recruiting 11Unknown 9Active not recruiting 9Terminated 8Not yet recruiting 7Withdrawn 4Suspended 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Head & Neck 1Genitourinary 1

Conditions

Cholangiocarcinoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Klatskin Tumor 1

Interventions

Cisplatin 10Gemcitabine 7Fluorouracil 7Carboplatin 7Capecitabine 7venetoclax 6Oxaliplatin 5Cyclophosphamide 4Azacitidine 4sintilimab 3Radiotherapy 3Neoadjuvant Therapy 3Dexamethasone 3Bevacizumab 3130-nm albumin-bound paclitaxel 3trametinib 2regorafenib 2pembrolizumab 2nimotuzumab 2fludarabine 2disitamab vedotin 2daratumumab 2dabrafenib 2camrelizumab 2blinatumomab 2apatinib 2Trastuzumab 2Temozolomide 2Radiotherapy, Intensity-Modulated 2Radiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2/3 × Not yet recruiting × Gemcitabine × Clear all
NCT07608224 2026-05-27

HOPE-07-MIBC

West China Hospital

Phase 2/3 Not yet recruiting
240 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT07598318 2026-05-20

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

Sir Run Run Shaw Hospital

Phase 2/3 Not yet recruiting
164 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT07544056 2026-04-22

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

BeBetter Med Inc

Phase 2/3 Not yet recruiting
446 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07366840 2026-01-26

BRIGHT

Fudan University

Phase 2/3 Not yet recruiting
268 enrolled
Breast

Breast Neoplasms

NCT06923475 2025-04-11

NEODISCO

Amsterdam UMC, location VUmc

Phase 2/3 Not yet recruiting
150 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06268327 2024-02-20

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

Assiut University

Phase 2/3 Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Sun Yat-sen University

Phase 2/3 Not yet recruiting
622 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡